StonvexLoading…
StonvexStonvexStonvexCore line items from ANDG's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Annual 2025 2025-12-31 | Annual 2024 2024-12-31 | Annual 2023 2023-12-31 |
|---|---|---|---|
Revenue | $838.69M | $731.59M | $639.11M |
Operating Income | $-135.29M | $129.54M | $116.86M |
Net Income | $-2.32M | $134.80M | $118.68M |
EPS (Diluted) | $-0.22 | Not available | Not available |
Total Assets | $565.14M | $398.69M | Not available |
Total Liabilities | $593.52M | $202.44M | Not available |
Cash & Equivalents | $250.28M | $87.99M | $71.71M |
Free Cash Flow OCF − CapEx | $174.27M | $143.72M | $113.17M |
Shares Outstanding | 110.94M | Not available | Not available |